Jacek Skarbinski to Cardiovascular Diseases
This is a "connection" page, showing publications Jacek Skarbinski has written about Cardiovascular Diseases.
Connection Strength
0.221
-
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64.
Score: 0.127
-
Cardiovascular Disease Risk Prediction in the HIV Outpatient Study. Clin Infect Dis. 2016 Dec 01; 63(11):1508-1516.
Score: 0.094